Algert Global LLC Mei Pharma, Inc. Transaction History

Algert Global LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.42 - $0.65 $5,905 - $9,139	-14,060 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.54 - $2.74 $7,592 - $38,524	14,060 New	14,060 $8,000
Q2 2020 Aug 12, 2020	SELL	$1.45 - $4.3 $21,300 - $63,167	-14,690 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$0.75 - $2.55 $27,350 - $92,990	-36,467 Reduced 71.28%	14,690 $24,000
Q3 2019 Nov 14, 2019	BUY	$1.48 - $2.52 $18,292 - $31,147	12,360 Added 31.86%	51,157 $86,000
Q2 2019 Aug 14, 2019	BUY	$2.45 - $3.32 $48,772 - $66,091	19,907 Added 105.38%	38,797 $97,000
Q1 2019 May 01, 2019	BUY	$2.52 - $3.24 $47,602 - $61,203	18,890 New	18,890 $58,000
Q4 2018 Feb 01, 2019	SELL	$1.92 - $4.1 $28,283 - $60,397	-14,731 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$3.39 - $4.61 $49,938 - $67,909	14,731 New	14,731 $63,000
Q2 2018 Aug 02, 2018	SELL	$1.89 - $4.95 $189,264 - $495,693	-100,140 Closed	0 $0
Q1 2018 May 03, 2018	SELL	$2.06 - $2.38 $275,533 - $318,334	-133,754 Reduced 57.19%	100,140 $207,000
Q4 2017 Feb 01, 2018	BUY	$1.91 - $2.83 $28,816 - $42,696	15,087 Added 6.9%	233,894 $491,000
Q3 2017 Nov 17, 2017	BUY	$2.44 - $2.91 $533,889 - $636,728	218,807	218,807 $586,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $344M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.